NASDAQ · ASBPWHealthcarePharmaceuticals

Aspire-Lakewood Holdings, Inc. Warrant financials

$0.0133−32.83%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Q3 '25
Sep 30
Q2 '25
Jun 30
Q1 '25
Mar 31
Revenue$63.1K$28.4K$4.3K$1.9K$0.00$0.00
Gross profit$12.3K$5.8K-$1.0K$884.00$0.00$0.00
Gross margin19.5%20.3%−23.5%45.5%——
Operating income-$2.7M-$1.6M-$1.8M-$1.1M-$799.9K-$15.6M
Net income-$1.3M-$3.2M-$4.7M-$1.9M-$2.0M-$15.9M
Net margin−2009.6%−11367.0%−110484.3%−95337.1%——
Diluted EPS$-1.22$-20.57—$-48.00$-48.19$-504.88
EBITDA-$2.4M-$1.6M-$1.8M-$1.1M-$799.9K-$15.6M
Operating cash flow-$2.1M-$3.0M-$927.8K-$1.1M-$1.1M-$1.8M
Free cash flow-$2.1M-$3.0M-$927.8K-$1.1M-$1.1M-$1.8M
Diluted shares1.0M0.2M—0.0M0.0M0.0M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30Jun 30Mar 31
Cash & equivalents$12.2M$5.9M$1.0M$1.9M$206.2K$1.3M
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$2.8M$6.2M$6.1M$4.9M
Total assets$13.5M$7.1M$1.3M$2.4M$989.4K$2.0M
Total liabilities$1.8M$3.2M$7.7M$13.9M$10.6M$9.9M
Shareholders' equity$11.8M$3.9M-$6.4M-$11.5M-$9.6M-$8.0M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology